FDA CDER Regulatory Science: The Importance of Partnership and Consortia

Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research within the United States Food and Drug Administration, explains how the FDA works with academic researchers, pharmaceutical companies, and other healthcare organizations to help identify scientific gaps in drug development. Find out how these partnerships and consortia improve FDA’s ability to review drugs.

 

share
Facebook